See more : Foley Wines Limited (FWL.NZ) Income Statement Analysis – Financial Results
Complete financial analysis of SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SYN-TECH Chem. & Pharm. Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
- Xinyi Energy Holdings Limited (3868.HK) Income Statement Analysis – Financial Results
- Compañía Minera Autlán, S.A.B. de C.V. (AUTLANB.MX) Income Statement Analysis – Financial Results
- Shang Gong Group Co., Ltd. (600843.SS) Income Statement Analysis – Financial Results
- Dunedin Income Growth Investment Trust PLC (DIG.L) Income Statement Analysis – Financial Results
- ICICI Prudential Life Insurance Company Limited (ICICIPRULI.BO) Income Statement Analysis – Financial Results
SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO)
About SYN-TECH Chem. & Pharm. Co., Ltd.
SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan and internationally. The company offers products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, antiulcerative, dipeptidyl peptidase 4 inhibitor/antidiabetic, antihyertensive, a- blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anesthetic, decongestant, antispasmodic, neuroprotective, antimigraine, hvponatremia, antiglaucoma agent, pharmaceutic aid / lubricant, sedative, and analgesic. SYN-TECH Chem. & Pharm. Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.11B | 986.30M | 893.23M | 983.79M | 946.41M | 784.83M | 694.99M | 766.79M |
| Cost of Revenue | 705.17M | 625.32M | 609.22M | 619.13M | 647.61M | 540.09M | 500.74M | 471.60M |
| Gross Profit | 409.52M | 360.98M | 284.02M | 364.66M | 298.81M | 244.74M | 194.25M | 295.19M |
| Gross Profit Ratio | 36.74% | 36.60% | 31.80% | 37.07% | 31.57% | 31.18% | 27.95% | 38.50% |
| Research & Development | 37.91M | 36.83M | 36.48M | 24.00M | 24.10M | 28.58M | 27.41M | 33.61M |
| General & Administrative | 46.51M | 44.66M | 42.16M | 43.69M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 43.21M | 45.25M | 44.13M | 38.23M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 89.73M | 85.92M | 78.95M | 78.29M | 74.09M | 66.66M | 65.35M | 73.40M |
| Other Expenses | 0.00 | 118.50M | 33.51M | -28.99M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 127.67M | 122.75M | 115.43M | 102.29M | 98.20M | 95.24M | 92.77M | 107.01M |
| Cost & Expenses | 832.84M | 748.07M | 724.65M | 721.42M | 745.80M | 635.33M | 593.50M | 578.61M |
| Interest Income | 29.73M | 16.01M | 2.26M | 6.22M | 14.91M | 11.50M | 4.66M | 1.45M |
| Interest Expense | 5.74M | 5.92M | 3.39M | 3.50M | 5.39M | 4.62M | 1.83M | 166.00K |
| Depreciation & Amortization | 111.75M | 80.85M | 71.45M | 70.77M | 69.57M | 61.55M | 51.23M | 36.69M |
| EBITDA | 430.56M | 319.08M | 240.04M | 333.14M | 270.18M | 211.06M | 152.72M | 224.87M |
| EBITDA Ratio | 38.63% | 32.35% | 26.87% | 33.86% | 28.55% | 26.89% | 21.97% | 29.33% |
| Operating Income | 281.85M | 238.23M | 168.59M | 262.37M | 200.61M | 149.50M | 101.48M | 188.18M |
| Operating Income Ratio | 25.29% | 24.15% | 18.87% | 26.67% | 21.20% | 19.05% | 14.60% | 24.54% |
| Total Other Income/Expenses | 31.92M | 128.60M | 32.37M | -29.46M | -336.00K | 42.56M | -24.25M | 5.21M |
| Income Before Tax | 313.77M | 366.82M | 200.96M | 236.10M | 200.27M | 192.07M | 77.24M | 193.39M |
| Income Before Tax Ratio | 28.15% | 37.19% | 22.50% | 24.00% | 21.16% | 24.47% | 11.11% | 25.22% |
| Income Tax Expense | 62.76M | 59.95M | 23.07M | 46.17M | 43.45M | 38.08M | 17.46M | 34.92M |
| Net Income | 251.01M | 295.29M | 177.16M | 186.74M | 159.47M | 153.99M | 59.78M | 158.47M |
| Net Income Ratio | 22.52% | 29.94% | 19.83% | 18.98% | 16.85% | 19.62% | 8.60% | 20.67% |
| EPS | 5.63 | 6.62 | 5.03 | 6.00 | 5.13 | 4.95 | 1.92 | 5.09 |
| EPS Diluted | 5.62 | 6.61 | 5.02 | 5.99 | 5.12 | 4.95 | 1.92 | 5.09 |
| Weighted Avg Shares Out | 44.58M | 44.59M | 35.25M | 31.10M | 31.10M | 31.10M | 31.10M | 31.10M |
| Weighted Avg Shares Out (Dil) | 44.68M | 44.66M | 35.28M | 31.16M | 31.14M | 31.13M | 31.12M | 31.13M |
Source: https://incomestatements.info
Category: Stock Reports